Ph3 Study of Volrustomig (MEDI5752) Advanced-HNSCC LA-HNSCC (eVOLVE-HNSCC)

Phase III Clinical Trial

A Phase III Randomized Open-Label Multi-Center Global Study of Volrustomig as Sequential Therapy Versus Observation in Participants with Unresected Locally Advanced-Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC) D798EC00001

Indication: Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer, Head and Neck Cancer
Trial Number: 06129864
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations